In a landmark discovery that bridges nearly a century of theoretical physics, a Chinese research team has successfully ...

When a delicate object crashes onto the floor, most people expect it to shatter into several pieces. What they might not know, however, is that the sizes of those fragments—whether from a broken plate ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Fluconazole (Mycorest (150 mg)) is an antifungal ...

Virgin Media O2 announced further steps toward its net zero carbon emissions goal through a new long-term Power Purchase Agreement with The Renewables Infrastructure Group (TRIG). As part of the ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

Thank you very much, operator, and good afternoon, everybody, and thank you for joining the Compass Second Quarter 2025 Earnings Call. Joining us today will be Robert Reffkin, our Founder and CEO; and ...

Compass Inc. reported its Q2 2025 earnings with revenue reaching $2.06 billion, showing a 21.1% increase year-over-year, and adjusted EBITDA rising to $126 million. Despite this growth, the company ...

—W.B. Yeats, "The Second Coming" Mainstream media coverage of the Israel-Iran conflict often pivots on proxies, retaliation, and regional instability. Analysts debate whether Tehran's reach into ...

Do the equations of physics find their way into the daily life of a cat? This is the intriguing question posed by Anxo Biasi, a researcher at the Instituto Galego de Física de Altas Enerxías. Inspired ...

Cebuana Lhuillier, the country’s leading and most trusted microfinance services provider, has joined forces with MG Forex Corporation, a recognized authority in the Philippine foreign exchange ...

Magna International recently raised its earnings guidance for 2025 to forecast higher sales, and reported strong Q1 2025 earnings with a net income surge from $9 million to $146 million, significantly ...

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus ® (oral semaglutide) significantly reduced the risk of major adverse ...